Clinic
VHS Brownsville Hospital Company LLC
VHS Brownsville Hospital Company LLC was paid $14.04M by Medicaid between Mar 2019 and Dec 2024, across 128 billing codes. Its largest line is 99284, emergency room visit (serious) — 35% of everything it billed.
33Billing provider infoVHS BROWNSVILLE HOSPITAL COMPANY LLC
BROWNSVILLE, TX 78520
BROWNSVILLE, TX 78520
33aNPI1184911877assigned 07/01/2011
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$14.04M
24GClaims248,450
24DCodes billed128
24AFirst – last monthMar 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#34 of 320
Median peer was paid$205K
This provider vs. median69×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 778 | $21K | |
| 2020 | 6,497 | $298K | |
| 2021 | 67,787 | $3.44M | |
| 2022 | 77,581 | $4.87M | |
| 2023 | 64,408 | $3.86M | |
| 2024incomplete | 31,399 | $1.54M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 35% | 14,485 | 13,719 | $4.98M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 7,345 | 6,806 | $2.66M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.5% | 15,330 | 14,793 | $1.33M |
| 80053 | Comprehensive metabolic panel | 4.0% | 18,639 | 16,608 | $565K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.9% | 11,081 | 8,551 | $407K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 7,177 | 6,500 | $364K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 20,767 | 18,562 | $327K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 7,614 | 7,366 | $322K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 1,260 | 1,187 | $245K |
| 71045 | Radiologic examination, chest; single view | 1.6% | 5,977 | 5,563 | $228K |
| 87088 | 1.5% | 9,358 | 8,813 | $213K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 1,999 | 1,506 | $176K |
116 more codes
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.3% | 2,106 | $176K |
| 99218 | <1% | 476 | $137K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,852 | $132K |
| G0378 | Hospital observation service, per hour | <1% | 1,417 | $123K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,437 | $119K |
| 76801 | <1% | 796 | $93K | |
| 81001 | <1% | 8,847 | $93K | |
| 87430 | <1% | 3,734 | $91K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,120 | $81K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 705 | $80K |
| 81025 | <1% | 3,682 | $61K | |
| 84703 | <1% | 2,399 | $57K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,524 | $53K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 346 | $50K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 160 | $50K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,545 | $47K |
| 83690 | <1% | 3,983 | $39K | |
| 87040 | <1% | 2,393 | $37K | |
| 87081 | <1% | 3,398 | $36K | |
| 81003 | <1% | 4,868 | $36K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 264 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,533 | $32K |
| 86850 | <1% | 1,754 | $28K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,375 | $27K |
| 84484 | <1% | 3,502 | $27K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 649 | $24K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,004 | $24K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 675 | $24K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 308 | $22K |
| 83605 | <1% | 1,697 | $22K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 14 | $21K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,957 | $21K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,803 | $21K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,836 | $21K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,231 | $18K |
| 84702 | <1% | 1,310 | $17K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,189 | $14K |
| 83880 | <1% | 958 | $13K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 68 | $13K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,008 | $11K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 927 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 980 | $10K |
| 87420 | <1% | 556 | $10K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 4,024 | $9K |
| 85610 | <1% | 3,287 | $9K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 76 | $9K |
| 87077 | <1% | 1,466 | $8K | |
| 87186 | <1% | 1,301 | $7K | |
| 85730 | <1% | 2,625 | $7K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 679 | $6K |
| 43235 | <1% | 12 | $5K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $5K |
| 86901 | <1% | 2,163 | $5K | |
| 86900 | <1% | 2,165 | $5K | |
| 11721 | <1% | 1,368 | $5K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 12 | $5K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 52 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 85 | $4K |
| 82746 | <1% | 89 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,583 | $4K |
| G0379 | Direct admission of patient for hospital observation care | <1% | 82 | $4K |
| 74018 | <1% | 98 | $4K | |
| 82248 | <1% | 730 | $4K | |
| 83735 | <1% | 1,354 | $4K | |
| 80061 | Lipid panel | <1% | 490 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,370 | $3K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 40 | $3K |
| 82550 | <1% | 698 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 665 | $3K |
| 82247 | <1% | 547 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 481 | $3K |
| 82150 | <1% | 423 | $2K | |
| 82607 | <1% | 92 | $2K | |
| 85027 | <1% | 1,095 | $2K | |
| 76641 | <1% | 16 | $2K | |
| 87070 | <1% | 501 | $2K | |
| 84145 | <1% | 63 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 301 | $1K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 28 | $1K |
| 96376 | <1% | 239 | $1K | |
| 97803 | <1% | 930 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 22 | $1K |
| 85379 | <1% | 193 | $993.16 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,085 | $670.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 282 | $584.64 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 175 | $487.56 |
| 82140 | <1% | 116 | $399.63 | |
| 82803 | <1% | 45 | $391.57 | |
| 97802 | <1% | 161 | $390.78 | |
| 94664 | <1% | 37 | $382.98 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 44 | $361.44 |
| J1741 | Injection, ibuprofen, 100 mg | <1% | 43 | $255.62 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 27 | $231.44 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 56 | $207.76 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 81 | $207.48 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 42 | $207.18 |
| A9270 | Non-covered item or service | <1% | 2,357 | $186.95 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,197 | $184.48 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 13 | $148.65 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 22 | $117.56 |
| 80305 | <1% | 15 | $77.14 | |
| C1769 | Guide wire | <1% | 13 | $72.55 |
| 87467 | <1% | 17 | $52.08 | |
| 88304 | <1% | 13 | $45.51 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 164 | $38.88 |
| 87340 | <1% | 14 | $31.43 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 12 | $26.96 |
| S0028 | Injection, famotidine, 20 mg | <1% | 13 | $24.95 |
| 82565 | <1% | 14 | $16.16 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 65 | $13.09 |
| 84520 | <1% | 14 | $12.48 | |
| 82962 | <1% | 3,341 | $7.48 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 31 | $2.30 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 40 | $0.00 |
| 88312 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVELA, JOSE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Moron Vela INC | Mission, TX | $4.20M |
| Simcha, INC. | Brownsville, TX | $1.81M |
| Simcha, INC. | Palmview, TX | $1.61M |
| Gse Health Care INC. | Raymondville, TX | $880K |
| Gse Health Care INC. | Harlingen, TX | $824K |
| Gse Health Care INC. | Edcouch, TX | $634K |
| One Medical Home Care, LLC | San Benito, TX | $53K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.